Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company engages in the discovery, development, and production of medicines.
Biochem Pharmaceutical Industries Limited Part Ix, was an unlisted public company incorporated on 04 November, 2004. It is classified as a public limited company and is located in , Gujarat. It's authorized share capital was INR 12.00 cr and the total paid-up capital was INR 7.50 cr.
Read more
** All rupee values in INR crores.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ganesh Narayan Nayak | 00017481 | 14 years |
| Director | Nitinkumar Dalsukhray Parekh | 00155570 | 14 years |
| Director | Deevyeshkumar Jagjivan Radia | 00297736 | 11 years |
| Director | Bhavana Sharadchandra Doshi | 02067636 | 11 years |
| Director | Anilkumar Matai | 03122685 | 11 years |
| Director | Mayank Jashwantlal Shah | 00384641 | 21 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 40.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| FINEST PROCURING SOLUTIONS LIMITED |
Amalgamated
|
4.0 Cr | 2 | Delhi |
| ALIDAC PHARMACEUTICALS LIMITED |
Amalgamated
|
99.3 Cr | 2 | Gujarat |
| ZYDUS BSV RESEARCH AND DEVELOPMENT PRIVA TE LIMITED |
Amalgamated
|
2.0 Cr | 1 | Gujarat |
| ZYDUS VTEC LIMITED |
Active
|
302.5 Cr | 1 | Gujarat |
| ZYDUS TECHNOLOGIES LIMITED |
Amalgamated
|
59.0 Cr | 1 | Gujarat |
| ZYDUS ANIMAL HEALTH LIMITED |
Amalgamated
|
24.0 Cr | 2 | Gujarat |
| ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED |
Active
|
15.0 Cr | 1 | Gujarat |
| ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED |
Active
|
20.0 Cr | 1 | Maharashtra |
| GERMAN REMEDIES HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| ZYDUS WELLNESS LIMITED |
Active
|
63.6 Cr | 1 | Gujarat |
| ZYDUS LIFESCIENCES LIMITED |
Active
|
100.6 Cr | 1 | Gujarat |
| LIVA HEALTHCARE LIMITED |
Amalgamated
|
90.8 L | 1 | Gujarat |
| DIALFORHEALTH GREENCROSS LIMITED |
Active
|
25.0 L | 1 | Gujarat |
| ZYDUS STRATEGIC INVESTMENTS LIMITED |
Active
|
1.0 Cr | 1 | Gujarat |
| ZYDUS HEALTHCARE LIMITED |
Amalgamated
|
10.0 Cr | 1 | Gujarat |
| UNITED NET WORKS PVT LTD |
Under Process of Striking Off
|
5.7 L | 1 | Gujarat |
| FUTURA SERVICES PVT LTD |
Strike Off
|
1.0 L | 1 | Gujarat |
| TRIDENT (INDIA) LIMITED |
Active
|
98.7 L | 1 | |
| ZYDUS HEALTHCARE LIMITED |
Active
|
21.6 Cr | 1 | Gujarat |
| PRATITI TRADING PRIVATE LIMITED |
Active
|
4.0 L | 1 | Maharashtra |
| GAJENDRA INVESTMENT LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| MJ SHAH REALTORS LLP |
Active
|
1.0 L | 1 | Maharashtra |
| MAULI HOTEL VENTURES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| MJ SHAH PROJECTS LLP |
Active
|
1.0 L | 1 | Maharashtra |
| MJ SHAH MARKETING LLP |
Active
|
1.0 L | 1 | Maharashtra |
| VIDHI RESEARCH & DEVELOPMENT LLP |
Active
|
1.0 L | 1 | Maharashtra |
| TOYOCHEM PHARMA (BOMBAY) PRIVATE LIMITED |
Active
|
2.7 L | 1 | Maharashtra |
| LIVA NUTRITIONS LIMITED |
Active
|
3.0 Cr | 1 | Gujarat |
| RPG LIFE SCIENCES LIMITED |
Active
|
13.2 Cr | 1 | Maharashtra |
Read more
The incorporation date of BIOCHEM PHARMACEUTICAL INDUSTRIES LIMITED PART IX is 04 November, 2004
The authorized share capital of BIOCHEM PHARMACEUTICAL INDUSTRIES LIMITED PART IX is INR ₹ 12.0 Cr.
The paid-up capital of BIOCHEM PHARMACEUTICAL INDUSTRIES LIMITED PART IX is INR ₹ 7.5 Cr.
The registered address of BIOCHEM PHARMACEUTICAL INDUSTRIES LIMITED PART IX is ZydusTower,SatelliteCrossRoad,Sarkhej-GandhinagarHighway, Ahmedabad, Ahmedabad, Gujarat, India, 380015 - 380015
The CIN number of BIOCHEM PHARMACEUTICAL INDUSTRIES LIMITED PART IX is U24230GJ2004PLC094323.